|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017725,
umls-concept:C0027651,
umls-concept:C0033204,
umls-concept:C0205179,
umls-concept:C0311400,
umls-concept:C0444706,
umls-concept:C0445204,
umls-concept:C0678790,
umls-concept:C0684249,
umls-concept:C0872169,
umls-concept:C1517927,
umls-concept:C1521733,
umls-concept:C1521828,
umls-concept:C2587213
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2002-11-6
|
|
pubmed:abstractText |
To determine the dose-response relationship between the probability of tumor control on the basis of pathologic tumor response (pTCP) and the residual metabolic rate of glucose (MRglc) in response to preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer and to define the level of residual MRglc that corresponds to pTCP 50% and pTCP > or = 95%.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1024-35
|
|
pubmed:dateRevised |
2010-3-23
|
|
pubmed:meshHeading |
pubmed-meshheading:12419428-Adult,
pubmed-meshheading:12419428-Aged,
pubmed-meshheading:12419428-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:12419428-Combined Modality Therapy,
pubmed-meshheading:12419428-Dose-Response Relationship, Radiation,
pubmed-meshheading:12419428-Female,
pubmed-meshheading:12419428-Fluorodeoxyglucose F18,
pubmed-meshheading:12419428-Glucose,
pubmed-meshheading:12419428-Humans,
pubmed-meshheading:12419428-Lung Neoplasms,
pubmed-meshheading:12419428-Male,
pubmed-meshheading:12419428-Middle Aged,
pubmed-meshheading:12419428-Probability,
pubmed-meshheading:12419428-Tomography, Emission-Computed
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, 100 Blossom Street, Boston, MA 02114, USA. nchoi@partners.org
|
|
pubmed:publicationType |
Journal Article
|
